Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Warning: imagejpeg(C:\Inetpub\vhosts\kidney.de\httpdocs\phplern\25885427
.jpg): Failed to open stream: No such file or directory in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 117 Blood+Cancer+J
2015 ; 5
(4
): e307
Nephropedia Template TP
gab.com Text
Twit Text FOAVip
Twit Text #
English Wikipedia
Drug screen in patient cells suggests quinacrine to be repositioned for treatment
of acute myeloid leukemia
#MMPMID25885427
Eriksson A
; Österroos A
; Hassan S
; Gullbo J
; Rickardson L
; Jarvius M
; Nygren P
; Fryknäs M
; Höglund M
; Larsson R
Blood Cancer J
2015[Apr]; 5
(4
): e307
PMID25885427
show ga
To find drugs suitable for repositioning for use against leukemia, samples from
patients with chronic lymphocytic, acute myeloid and lymphocytic leukemias as
well as peripheral blood mononuclear cells (PBMC) were tested in response to 1266
compounds from the LOPAC(1280) library (Sigma). Twenty-five compounds were
defined as hits with activity in all leukemia subgroups (<50% cell survival
compared with control) at 10 ?M drug concentration. Only one of these compounds,
quinacrine, showed low activity in normal PBMCs and was therefore selected for
further preclinical evaluation. Mining the NCI-60 and the NextBio databases
demonstrated leukemia sensitivity and the ability of quinacrine to reverse
myeloid leukemia gene expression. Mechanistic exploration was performed using the
NextBio bioinformatic software using gene expression analysis of drug exposed
acute myeloid leukemia cultures (HL-60) in the database. Analysis of gene
enrichment and drug correlations revealed strong connections to ribosomal
biogenesis nucleoli and translation initiation. The highest drug-drug correlation
was to ellipticine, a known RNA polymerase I inhibitor. These results were
validated by additional gene expression analysis performed in-house. Quinacrine
induced early inhibition of protein synthesis supporting these predictions. The
results suggest that quinacrine have repositioning potential for treatment of
acute myeloid leukemia by targeting of ribosomal biogenesis.
|*Drug Screening Assays, Antitumor
[MESH]
|Antineoplastic Agents/isolation & purification/therapeutic use
[MESH]